CYBERKNIFE SYSTEM

Right Central Lung Metastasis

Case History

AGE: 62-year-old
GENDER: Male

Medical History

  • Chronic obstructive pulmonary disease (COPD), previous surgery on right lung
  • Chest CT: Suspicious lesion in the right lower lobe
  • PET-CT: hypermetabolic nodule, 3.1cm no evidence of regional or distant metastasis
  • Non-Small Cell Lung Cancer (NSCLC), adenocarcinoma cT2aN0M0, Stage IB

Hypertension and smoker with a 60-pack-year history.

Persistent cough and unintentional weight loss over the past three months

Planning CT Images

Treatment Plan Images

Treatment Planning Highlights

Fractionation

60 Gy in 8 fractions

PTV(s) Volume

21.8cc

Dose Distributions

  • Prescription to the
    78.9% isodose line
  • Max. dose 76.05 Gy

Collimator

MLC

Dose Calculation Algorithm

Monte-Carlo

New Conformality Index (nCI)

nCi = 1.22

Gradient Index (GI)

GI = 4.24

Protocol Used

RECORAD

Treatment Delivery Information

Tracking Method

Lung Tracking with Respiratory Modelling

Total Delivery Time

29 minutes

Medical Affairs

Accuray Medical Affairs serves as your comprehensive resource hub for clinical evidence, and peer collaboration through our user community.

Services

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

Solutions

From robotic to helical radiation therapy delivery, we invent unique, market-changing solutions that are designed to deliver radiation treatments across a full spectrum of patient needs.

Treatment Centers

Radiosurgery

Adaptive Radiotherapy

What's New

Your go-to source for staying informed about our advancements.

Why Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.